Editor's Note: Michael's Strategic Tech Investor subscribers get his latest marijuana industry updates as soon as they're released. You can join them – and ensure you never miss an issue – by clicking here. It's free!
On Friday, Feb. 2, Michael and his team attended the International Cannabis Business Conference in San Francisco in order to investigate the current state of legal marijuana – and what's on the horizon.
There are a ton of new ideas out there. The growers and dispensaries/retailers – the "pure plays" – were literally the least of it. The amount of startups with new technologies and services for legal cannabis companies on the conference floor seemed limitless. We lost track of how many entrepreneurs and budding CEOs Michael got to talk to. Frankly, it was dizzying.
Plus, we checked out plenty of biotech companies developing medicinal marijuana treatments, chatted with state officials helping companies set up their licenses, and visited all kinds of firms displaying their cannabis-infused "edibles" and "topicals" – i.e., foods and skin care products.
It's no wonder so many entrepreneurs are getting into this space… If the forecasts Michael trusts are correct, the North American legal cannabis market is going to grow by 26% annually through 2021. And the industry will be generating almost $22 billion in sales by 2021 – triple what it did in 2016. You can't ignore that kind of growth. To us, getting in on cannabis now is like getting in on Silicon Valley… in 1965. Michael tells you more about that in the video below…
How to Cash In Thanks to California's Legal Cannabis: People have accumulated massive gains from previous marijuana legalization announcements, but this event could blow the lid off of anything we've seen so far. In a special interview, our penny pot stock expert, Michael Robinson, shows ordinary people how to potentially make millions from California's Jan. 1 marijuana legislation – starting with three tiny stocks expected to explode following legalization. Watch now…
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.